Segregating two inhibitory circuits in human motor cortex at the level of GABAA receptor subtypes: A TMS study

Clinical Neurophysiology

Volumn 118, Issue 10, 2007, Pages 2207-2214

  Di Lazzaro, V ^a,b   Pilato, F ^a   Dileone, M ^a   Profice, P ^a   Ranieri, F ^a   Ricci, V ^a   Bria, P ^a   Tonali, P A ^a,b   Ziemann, U ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Benzodiazepines; Short interval intracortical inhibition; Short latency afferent inhibition; Transcranial magnetic stimulation

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DIAZEPAM; LORAZEPAM; ZOLPIDEM;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HUMAN; MOTOR CORTEX; NORMAL HUMAN; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; CEREBRAL CORTEX; CROSS-OVER STUDIES; DIAZEPAM; EVOKED POTENTIALS, MOTOR; GABA AGONISTS; GABA MODULATORS; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MOTOR CORTEX; NEURONS, AFFERENT; PYRIDINES; RECEPTORS, GABA-A; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 34548522539     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2007.07.005     Document Type: Article

References (55)

1. Bacci A., Rudolph U., Huguenard J.R., and Prince D.A. Major differences in inhibitory synaptic transmission onto two neocortical interneuron subclasses. J Neurosci 23 (2003) 9664-9674
2. Chernik D.A., Gillings D., Laine H., Hendler J., Silver J.M., Davidson A.B., et al. Validity and reliability of the observer's assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 10 (1990) 244-251
3. Curran H.V., Schifano F., and Lader M. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology (Berl) 103 (1991) 83-90
4. Di Lazzaro V., Restuccia D., Oliviero A., Profice P., Ferrara L., Insola A., et al. Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits. Exp Brain Res 119 (1998) 265-268
5. Di Lazzaro V., Oliviero A., Meglio M., Cioni B., Tamburrini G., Tonali P., et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol 111 (2000) 794-799
6. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Di Giovanni S., Zito G., et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 135 (2000) 455-461
7. Di Lazzaro V., Oliviero A., Tonali P.A., Marra C., Daniele A., Profice P., et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 59 (2002) 392-397
8. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Mazzone P., et al. The physiological basis of transcranial motor cortex stimulation in conscious humans. Clin Neurophysiol 115 (2004) 255-266
9. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., et al. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75 (2004) 555-559
10. Di Lazzaro V., Oliviero A., Saturno E., Dileone M., Pilato F., Nardone R., et al. Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 564 (2005) 661-668
11. Di Lazzaro V., Pilato F., Dileone M., Tonali P.A., and Ziemann U. Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition. J Physiol 569 (2005) 315-323
12. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., et al. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 76 (2005) 1064-1069
13. Di Lazzaro V., Pilato F., Dileone M., Ranieri F., Ricci V., Profice P., et al. GABAA receptor subtype specific enhancement of inhibition in human motor cortex. J Physiol 575 (2006) 721-726
14. Fagiolini M., Fritschy J.M., Low K., Mohler H., Rudolph U., and Hensch T.K. Specific GABAA circuits for visual cortical plasticity. Science 303 (2004) 1681-1683
15. Freund T.F. Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci 26 (2003) 489-495
16. Fujiki M., Hikawa T., Abe T., Ishii K., and Kobayashi H. Reduced short latency afferent inhibition in diffuse axonal injury patients with memory impairment. Neurosci Lett 405 (2006) 226-230
17. Giorgetti M., Bacciottini L., Giovannini M.G., Colivicchi M.A., Goldfarb J., and Blandina P. Local GABAergic modulation of acetylcholine release from the cortex of freely moving rats. Eur J Neurosci 12 (2000) 1941-1948
18. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 406 (2000) 147-150
19. Hasselmo M.E., and Bower J.M. Acetylcholine and memory. Trends Neurosci 16 (1993) 218-222
20. Healey M., Pickens R., Meisch R., and McKenna T. Effects of clorazepate, diazepam, lorazepam, and placebo on human memory. J Clin Psychiatry 44 (1983) 436-439
21. Heisterkamp D.V., and Cohen P.J. The effect of intravenous premedication with lorazepam (ativan), pentobarbitone or diazepam on recall. Br J Anaesth 47 (1975) 79-81
22. Huntsman M.M., Woods T.M., and Jones E.G. Laminar patterns of expression of GABA-A receptor subunit mRNAs in monkey sensory motor cortex. J Comp Neurol 362 (1995) 565-582
23. Ilic T.V., Meintzschel F., Cleff U., Ruge D., Kessler K.R., and Ziemann U. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol 545 (2002) 153-167
24. Itil T., Shapiro D., Itil K.Z., Eralp E., Bergamo M., and Mucci A. Discrimination of mode of action of anxiolytics using an integrated computer data bank and dynamic brain mapping (CNS effects of diazepam and lorazepam). Int Clin Psychopharmacol 4 (1989) 273-283
25. Kawaguchi Y. Selective cholinergic modulation of cortical GABAergic cell subtypes. J Neurophysiol 78 (1997) 1743-1747
26. Kawaguchi Y., and Kondo S. Parvalbumin, somatostatin and cholecystokinin as chemical markers for specific GABAergic interneuron types in the rat frontal cortex. J Neurocytol 31 (2002) 277-287
27. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 471 (1993) 501-519
28. Kyriakopoulos A.A., Greenblatt D.J., and Shader R.I. Clinical pharmacokinetics of lorazepam: a review. J Clin Psychiatry 39 (1978) 16-23
29. Legrand F., Vidailhet P., Danion J.M., Grange D., Giersch A., Van der Linden M., et al. Time course of the effects of diazepam and lorazepam on perceptual priming and explicit memory. Psychopharmacology (Berl) 118 (1995) 475-479
30. Mintzer M.Z., and Griffiths R.R. Selective effects of zolpidem on human memory functions. J Psychopharmacol 13 (1999) 18-31
31. Mintzer M.Z., and Griffiths R.R. Lorazepam and scopolamine: a single-dose comparison of effects on human memory and attentional processes. Exp Clin Psychopharmacol 11 (2003) 56-72
32. Möhler H., Fritschy J.M., and Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300 (2002) 2-8
33. Möhler H., Fritschy J.M., Crestani F., Hensch T., and Rudolph U. Specific GABA(A) circuits in brain development and therapy. Biochem Pharmacol 68 (2004) 1685-1690
34. Möhler H. GABA(A) receptor diversity and pharmacology. Cell Tissue Res 326 (2006) 505-516
35. Möhler H. Molecular regulation of cognitive functions and developmental plasticity: impact of GABA(A) receptors. J Neurochem 102 (2007) 1-12
36. Olsen R.W., and Homanics G.E. Functions of GABAA receptors: insights from mutant and knock out mice. In: Martin D.L., and Olsen R.W. (Eds). GABA in the nervous system: the view at fifty years (2000), Lippincott Williams & Wilkins, Philadelphia 81-96
37. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., and Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101 (2000) 815-850
38. Pompéia S., Manzano G.M., Galduroz J.C., Tufik S., and Bueno O.F. Lorazepam induces an atypical dissociation of visual and auditory event-related potentials. J Psychopharmacol 17 (2003) 31-40
39. Pompéia S., Lucchesi L.M., Bueno O.F., Manzano G.M., and Tufik S. Zolpidem and memory: a study using the process-dissociation procedure. Psychopharmacology (Berl) 174 (2004) 327-333
40. Pompeia S., Manzano G.M., Tufik S., and Bueno O.F. What makes lorazepam different from other benzodiazepines?. J Physiol 569 (2005) 709
41. Ridding M.C., Taylor J.L., and Rothwell J.C. The effect of voluntary contraction on cortico-cortical inhibition in human motor cortex. J Physiol 487 (1995) 541-548
42. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401 (1999) 796-800
43. Salva P., and Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet 29 (1995) 142-153
44. Sellal F., Danion J.M., Kauffmann-Muller F., Grange D., Imbs J.L., Van der Linden M., et al. Differential effects of diazepam and lorazepam on repetition priming in healthy volunteers. Psychopharmacology (Berl) 108 (1992) 371-379
45. Shader R.I., Pary R.J., Harmatz J.S., Allison S., Locniskar A., and Greenblatt D.J. Plasma concentrations and clinical effects after single oral doses of prazepam, clorazepate, and diazepam. J Clin Psychiatry 45 (1984) 411-413
46. Sieghart W. Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev 47 (1995) 181-234
47. Stefan K., Kunesch E., Benecke R., Cohen L.G., and Classen J. Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation. J Physiol 543 (2002) 699-708
48. Tokimura H., Di Lazzaro V., Tokimura Y., Oliviero A., Profice P., Insola A., et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 523 (2000) 503-513
49. Vidailhet P., Kazes M., Danion J.M., Kauffmann-Muller F., and Grange D. Effects of lorazepam and diazepam on conscious and automatic memory processes. Psychopharmacology (Berl). 127 (1996) 63-72
50. Wagemans J., Notebaert W., and Boucart M. Lorazepam but not diazepam impairs identification of pictures on the basis of specific contour fragments. Psychopharmacology (Berl). 138 (1998) 326-333
51. Yee B.K., Keist R., von Boehmer L., Studer R., Benke D., Hagenbuch N., et al. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci USA 102 (2005) 17154-17159
52. Ziemann U., Lönnecker S., Steinhoff B.J., and Paulus W. Effects of antiepileptics drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 40 (1996) 367-378
53. Ziemann U., Lönnecker S., Steinhof B.J., and Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 109 (1996) 127-135
54. Ziemann U., Rothwell J.C., and Ridding M.C. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 496 (1996) 873-881
55. Ziemann U. TMS and drugs. Clin Neurophysiol 115 (2004) 1717-1729